PharmaBiome

PharmaBiome is a preclinical stage spin-off from ETH Zurich, combining key expertise in microbiology, biotechnology, and molecular disease mechanisms involving the microbiome. PharmaBiome has developed unique technology to access the full range of gut bacteria for large-scale design and production of function-based consortia.